ng-nitroarginine methyl ester has been researched along with Gangrene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castilla, D; Lassance-Soares, RM; Li, Y; Liu, ZJ; Parikh, PP; Regueiro, M; Shao, H; Vazquez-Padron, R; Velazquez, OC; Webster, KA | 1 |
Bagshahi, H; Hoffman, A; Messina, LM; Nowicki, PT; Park, B; Tie, G; Yan, J; Yang, Y | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Gangrene
Article | Year |
---|---|
A Reliable Mouse Model of Hind limb Gangrene.
Topics: Animals; Blood Flow Velocity; Disease Models, Animal; Femoral Artery; Gangrene; Hindlimb; Ischemia; Ligation; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peripheral Arterial Disease; Regional Blood Flow; Species Specificity; Time Factors | 2018 |
Endothelial nitric oxide synthase affects both early and late collateral arterial adaptation and blood flow recovery after induction of hind limb ischemia in mice.
Topics: Animals; Chemotaxis; Collateral Circulation; Disease Models, Animal; Enzyme Inhibitors; Gangrene; Hindlimb; Ischemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Receptors, CXCR4; Recovery of Function; Regional Blood Flow; Stem Cells; Time Factors; Toes; Vascular Endothelial Growth Factor Receptor-1 | 2010 |